2m 2m 2m 2m 2m 2m 2m
Lyra Therapeutcs (LYRA)
OTC
$0.35+$0.15 (+74.00%)
Price as of Mar 16, 2026 7:59 PM EDT- $781,125.00Market Cap
- -96.88%1-Year Change
- BiotechnologyIndustry
Lyra Therapeutcs (LYRA)
$0.35+$0.15 (+74.00%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 49
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.20
$0.20
$0.20
1-Year Range
$0.0004
$8.09
$0.20
Latest Close$0.20
Change
+$0.01 (+5.00%)
Volume110
Market Cap$781,125.00
Shares Outstanding1.8M
P/E (TTM)-0.02
Diluted EPS (TTM)-$22.95
Enterprise Value-$21.3M
Information as of 09/09/2026
Company Profile
LYRA THERAPEUTICS INC
$781,125.00
Market Cap
-$32.9M
Net Income
Sector: Healthcare
Industry: Biotechnology
LYRA THERAPEUTICS INC
Key Executives
- Vineeta Belanger
- Allison Nance
- Ronan O'Brien
- Elazer R. Edelman FACC
- Carmichael S. Roberts Jr.
Current Ownership Distribution
- Institutions367.4M (63.10%)
- Mutual Funds200.1M (34.36%)
- Insiders14.8M (2.55%)
- Other0 (0.00%)